AN2 Therapeutics (ANTX) Prepaid Assets (2021 - 2026)
AN2 Therapeutics' (ANTX) quarterly Prepaid Assets came in at $2.2 million in Q1 2026, down 11.84% year-on-year from $2.5 million in Q1 2025, and up 13.79% on a QoQ basis from $1.9 million in Q4 2025.
AN2 Therapeutics (ANTX) Prepaid Assets (2021 - 2026) Analysis & Trends
AN2 Therapeutics (ANTX) has 6 years of Prepaid Assets data on file, last reported at $2.2 million in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 11.84% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a 11.84% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 26.78% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.2 million, up from $1.9 million in the prior quarter.
- Over the last five years, Prepaid Assets for ANTX reached as high as $4.6 million in Q2 2025 and fell as low as $1.4 million in Q1 2022.
- Historically, Prepaid Assets has averaged $2.7 million across 5 years, with a median of $2.6 million in 2023.
- Across the five-year window, Prepaid Assets surged 64.53% in 2024 and sank 50.86% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $2.5 million in 2022, then climbed by 28.02% to $3.2 million in 2023, then declined by 17.68% to $2.6 million in 2024, then fell by 26.78% to $1.9 million in 2025, then advanced by 13.79% to $2.2 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $2.2 million in Q1 2026, $1.9 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AN2 Therapeutics | 167.57 Mn | 167.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 4.61 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 2.64 Mn |
| Sep 30, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 2.94 Mn |
| Mar 31, 2023 | 1.77 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.55 Mn |